Simplify Logo

Full-Time

Director – Informatics Data Systems

Posted on 4/30/2024

Generate Biomedicines

Generate Biomedicines

51-200 employees

Generates novel medicines using machine learning

AI & Machine Learning
Biotechnology

Senior, Expert

Cambridge, MA, USA

This role requires hybrid work based in the Somerville, MA office.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Data Science
AWS
Requirements
  • Master’s or PhD in Computer Science, Data Science, or related field plus 12 years of experience working in the pharmaceutical or biotech domain
  • Deep technical and architectural expertise in data storage, cloud architecture, microservices, etc.
  • Demonstrated excellence in software design and architecture
  • Demonstrated expertise in data management best practices for biological data
  • Experience building and maintaining production data pipelines
  • Deep understanding of cloud technologies (AWS a plus)
Responsibilities
  • Design, plan, and lead the development of a highly scalable and flexible assay data management platform, which: Captures and standardizes assay results and experiment context leveraging FAIR data principles, Enables optimized experiment design, Integrates with automation for high-throughput data generation, Produces training-ready data for rapid model development
  • Plan, architect, and lead development of data pipelines leveraging internal and external data sources
  • Maintain deep technical understanding of Generate’s data inventory, and design systems to support scientists’ access to data
  • Design and lead implementation of data models to support lab and ML workflows
  • Work with lab and computational scientists to: Identify needs and opportunities for platform improvement, Prioritize, plan, and implement, Drive adoption and change management
  • Design and lead development of analytical reports and dashboards
  • Lead, manage, mentor and develop a high-performance team of informatics software engineers
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. This approach involves analyzing millions of proteins to learn how nature encodes their functions, allowing the company to design new medicines with specific therapeutic effects. The main product, The Generate Platform, enables the rapid production of medicines across various therapeutic areas, significantly improving the drug discovery process compared to traditional methods. Unlike its competitors, Generate Biomedicines emphasizes a proactive and efficient approach to medicine creation, aiming to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating and testing proteins, having already produced 42,000 proteins, and to continue advancing the field of therapeutics.

Company Stage

Series C

Total Funding

$693M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

3%

1 year growth

15%

2 year growth

41%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $273M Series C financing round provides substantial capital to advance their generative AI pipeline and clinical programs.
  • Expansion of the leadership team with experienced professionals like Rupert Vessey, Nancy Simonian, and Kym White strengthens the company's strategic direction and operational capabilities.
  • Publication of the Chroma model in Nature highlights the company's innovative contributions to protein therapeutics, enhancing its reputation in the scientific community.

What critics are saying

  • The reliance on cutting-edge generative AI and machine learning technologies may face regulatory and adoption challenges in the conservative pharmaceutical industry.
  • Rapid expansion and scaling efforts, including new hires and leadership changes, could lead to integration and cultural challenges.

What makes Generate Biomedicines unique

  • Generate Biomedicines leverages generative biology and machine learning to create medicines on demand, a significant departure from traditional drug discovery methods.
  • The Generate Platform's ability to produce novel medicines across multiple therapeutic areas with high speed and success rates sets it apart from competitors.
  • Their focus on understanding the rules by which nature encodes function to design new proteins is a unique approach in the biotechnology sector.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE